MEDICAL male circumcision is gaining strength as a preventive measure against HIV/AIDS transmission.
Palabra clave ‘HIV infection’
Trials on an Aids vaccine that is generating a lot of excitement in the scientific world have finally started in Kenya with several volunteering for vaccination.
Vitamin D deficiency is highly prevalent in patients with HIV and is associated with an increased risk of disease progression, investigators from the EuroSIDA cohort report in the online edition of AIDS.
Project Ubuzima has entered the third of testing an anti-HIV gel for women. This is the final phase before the manufacturing of the product, which is believed to reduce the risk of HIV infection among women.
Media images of men in northern Kenya washing condoms for re-use have underscored the need to improve HIV communication and close gaps in the supply of condoms in rural areas.
Independent assessment indicates severe underrepresentation of gay men, transgender people, sex workers and people who use drugs at the biennial International AIDS Conference. A new report indicates that the International AIDS Conference (IAC), a biennial event convened by the International AIDS Society (IAS) that has become the worlds premier gathering for people working in the field of HIV, suffers from gross underrepresentation of populations most at risk for HIV infection, including men who have sex with men (MSM), transgender people, sex workers and people who use drugs. The independent audit, conducted by the Global Forum on MSM & HIV (MSMGF), confirms suspicions long-held by activist groups and calls for a comprehensive review of IAC governing structures.
Testing and treatment of sexually transmitted diseases (STDs) can be an effective tool in preventing the spread of HIV, the virus that causes AIDS. An understanding of the relationship between STDs and HIV infection can help in the development of effective HIV prevention programs for persons with high-risk sexual behaviors.
A new study presented suggested the potential of an anti-HIV gel in protecting rectal tissue cells from infection with the virus that causes AIDS.
The Italian and South African health departments plan to test the next phase of a vaccine against HIV on 200 people with chronic HIV, they said.
Project Ubuzima will spend the next three years conducting a research on an Anti-HIV gel for women following the approval by the Medical Ethics Committee. The vaginal gel is part of the microbicide medical products and is believed to reduce the risk of HIV infection among women.